NKTR - Nektar Therapeutics

Day 1m 10m 60m PreMarket Market AfterHours Gap
58.89 -1.99 (-3.38%) --- 0.3 (0.53%) 0.01 (0.02%) -1.28 (-2.17%) -1.11 (-1.91%) 0.01 (0.02%) 0.01 (0.02%)

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-2.95
Diluted EPS:
-2.95
Basic P/E:
-19.2881
Diluted P/E:
-19.2881
RSI(14) 1m:
50.85
VWAP:
56.9
RVol:
0.8549

Events

Period Kind Movement Occurred At
1m Price decrease 1m 57.86 -0.78 (-1.34%) Oct 15 09:36
1m Price decrease 1m 57.08 -1.17 (-2.01%) Oct 15 08:52
1m Price decrease 1m 59.0 -1.0 (-1.67%) Oct 14 19:50
1m Price decrease 1m 59.0 -2.5 (-4.07%) Oct 14 19:49
10m Price decrease 10m 59.0 -2.5 (-4.07%) Oct 14 19:49

Related News